P.A.W. Capital’s Bristol-Myers Squibb BMY Stock Holding History

P.A.W. Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.32M	Buy	92,300 +51,300	+125%	+$2.95M	1.69%	26
2026 Q1	$2.43M	Buy	+41,000	New	+$2.39M	1.95%	18
2022 Q4	–	Sell	-12,000	Closed	-$853K	–	29
2022 Q3	$853K	Hold	12,000	–	–	1.28%	20
2022 Q2	$924K	Sell	12,000 -1,000	-8%	-$76.2K	1.34%	17
2022 Q1	$949K	Sell	13,000 -2,000	-13%	-$134K	0.99%	29
2021 Q4	$935K	Buy	15,000 +3,000	+25%	+$176K	0.86%	30
2021 Q3	$710K	Buy	+12,000	New	+$790K	0.63%	57
2013 Q4	–	Sell	-8,000	Closed	-$370K	–	63
2013 Q3	$370K	Hold	8,000	–	–	0.31%	60
2013 Q2	$358K	Buy	+8,000	New	+$347K	0.3%	59

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

P.A.W. Capital's BMY Position: Q2 2026 in Review

P.A.W. Capital increased its Bristol-Myers Squibb (BMY) stake by 125% in Q2 2026, buying an estimated $2.95M and bringing the position to 92,300 shares worth $5.32M. The position accounts for 1.69% of the portfolio, ranked #26.

P.A.W. Capital first reported a position in BMY in Q2 2013 and has held it in 9 quarters since. 2,541 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

P.A.W. Capital held 92,300 shares of Bristol-Myers Squibb worth $5.32M as of Q2 2026.
P.A.W. Capital bought 51,300 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.95M.
Bristol-Myers Squibb made up 1.69% of P.A.W. Capital's portfolio in Q2 2026, its #26 holding.
P.A.W. Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 9 quarters since.
2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on P.A.W. Capital's 13F filing for Q2 2026, filed 28 Jul 2026.